Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 28, 2014; 20(32): 11054-11061
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11054
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11054
Ref. | DLBCL-HCV positive patients (n) | Treatment | PFS/EFS (3 yr) | OS (3 yr) |
Besson et al[16] | 26 | Intensive protocols | 53% | 56% |
Visco et al[14] | 156 | CHOP and CHOP-like/R-CHOP | 60% | 80% |
Park et al[15] | 32 | CHOP(18)/R-CHOP(11) | 54.7% at 5 yr | 59.2% at 5 yr |
Tomita et al[17] | 25 | CHOP/CHOP-like | NA | 46% |
Ennishi et al[60] | 131 | R-CHOP | 69% | 75% |
Merli et al[59] | 535 | CHOP(214)/+R-CHOP (252) | 53% | 68% |
(58% for R-CHOP) | (71% for R-CHOP) |
- Citation: Visco C, Finotto S. Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment. World J Gastroenterol 2014; 20(32): 11054-11061
- URL: https://www.wjgnet.com/1007-9327/full/v20/i32/11054.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i32.11054